Follow the Fluicell AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Fluicell AB has logged 5 insider filings. Market capitalisation: €49.5m. The latest transaction was filed on 9 March 2026 (Purchase). Among the most active insiders: Joakim Wahlberg. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€31,947
5 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €31,947n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,500 shares@ SEK 28.17100.0% of flowAktieISINISIN SE0010831321FI:A001P430-1
5 of 5 declarations
About Fluicell AB
Fluicell AB is a company focused on developing technologies for biomedical research. It offers innovative solutions for cellular analysis and tissue biology.